Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Corpechot

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Science Advances|December 17, 2025
RIPK1 inhibition reduces biliary injury and fibrosis in primary sclerosing cholangitisPierre-Antoine Soret, Virginie Steunou, Julien Hedou, et al.
The American Journal of Gastroenterology|December 13, 2017
Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and OutcomeMaren H Harms, Willem J Lammers, Douglas Thorburn, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 4, 2022
Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survivalFrançois Villeret, Sébastien Dharancy, Domitille Erard, et al.
Gut|December 18, 2019
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitisMaren H Harms, Rozanne C de Veer, Willem J Lammers, et al.
JHEP Reports : Innovation in Hepatology|February 28, 2023
Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosisFrançois Villeret, Sébastien Dharancy, Domitille Erard, et al.
The New England Journal of Medicine|February 21, 2024
A Phase 3 Trial of Seladelpar in Primary Biliary CholangitisGideon M Hirschfield, Christopher L Bowlus, Marlyn J Mayo, et al.
Gastroenterology|August 12, 2015
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid TherapyWillem J Lammers, Gideon M Hirschfield, Christophe Corpechot, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 17, 2019
Factors Associated With Progression and Outcomes of Early Stage Primary Biliary CholangitisNikolaos K Gatselis, Jorn C Goet, Kalliopi Zachou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 17, 2025
Development of a Question Prompt List for People Living With Primary Biliary Cholangitis: A Delphi StudyEllen Werner, Maria C B van Hooff, Gemma H X Weijsters, et al.
Gastroenterology|October 9, 2018
Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient SurvivalAldo J Montano-Loza, Bettina E Hansen, Christophe Corpechot, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Science Advances|December 17, 2025
RIPK1 inhibition reduces biliary injury and fibrosis in primary sclerosing cholangitisPierre-Antoine Soret, Virginie Steunou, Julien Hedou, et al.
The American Journal of Gastroenterology|December 13, 2017
Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and OutcomeMaren H Harms, Willem J Lammers, Douglas Thorburn, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 4, 2022
Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survivalFrançois Villeret, Sébastien Dharancy, Domitille Erard, et al.
Gut|December 18, 2019
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitisMaren H Harms, Rozanne C de Veer, Willem J Lammers, et al.
JHEP Reports : Innovation in Hepatology|February 28, 2023
Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosisFrançois Villeret, Sébastien Dharancy, Domitille Erard, et al.
The New England Journal of Medicine|February 21, 2024
A Phase 3 Trial of Seladelpar in Primary Biliary CholangitisGideon M Hirschfield, Christopher L Bowlus, Marlyn J Mayo, et al.
Gastroenterology|August 12, 2015
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid TherapyWillem J Lammers, Gideon M Hirschfield, Christophe Corpechot, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 17, 2019
Factors Associated With Progression and Outcomes of Early Stage Primary Biliary CholangitisNikolaos K Gatselis, Jorn C Goet, Kalliopi Zachou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 17, 2025
Development of a Question Prompt List for People Living With Primary Biliary Cholangitis: A Delphi StudyEllen Werner, Maria C B van Hooff, Gemma H X Weijsters, et al.
Gastroenterology|October 9, 2018
Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient SurvivalAldo J Montano-Loza, Bettina E Hansen, Christophe Corpechot, et al.
Pageof 12